NCT02518061View on ClinicalTrials.gov

11C-Methionine PET as Prognostic Marker of Gliomas

CompletedOBSERVATIONAL
Enrollment

145

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Glioma
Interventions
OTHER

No intervention

This is a retrospective study

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT02518061 - 11C-Methionine PET as Prognostic Marker of Gliomas | Biotech Hunter | Biotech Hunter